US EditionPublished • loading... • Updated
Editing the Genome to Treat: What Is the Status of Crispr Therapies and Their Derivatives?
Summary by Laminute.info
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
What looked like science fiction yesterday is now a clinical reality: the publishing of the human genome with CRISPR-Cas9 begins to cure incurable diseases. But what is the actual status of this announced revolution? Between first clinical successes, technical limitations and persistent ethical issues, the therapies from CRISPR draw a landscape where promises and prudence are now inextricably linked. We are witnessing a sharp rise in hopes for r…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
